Prosecution Insights
Last updated: November 12, 2026
Application No. 18/798,218

SYSTEM AND METHOD FOR NUCLEAR MAGNETIC RESONANCE MEASUREMENT OF BLOOD ANALYTE LEVELS

Non-Final OA §112
Filed
Aug 08, 2024
Priority
Aug 08, 2023 — provisional 63/531,405 +3 more
Examiner
YOON, CHANEL J
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Synex Medical Inc.
OA Round
1 (Non-Final)
56%
Grant Probability
Moderate
1-2
OA Rounds
94%
With Interview

Examiner Intelligence

Grants 56% of resolved cases
56%
Career Allowance Rate
123 granted / 221 resolved
-14.3% vs TC avg
Strong +39% interview lift
Without
With
+38.6%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
51 currently pending
Career history
290
Total Applications
across all art units

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 11-20 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected Invention II, there being no allowable generic or linking claim. Because the Applicant has not specified whether the election was made with or without traverse, the Examiner will assume that the election was made without traverse in the reply filed on August 7th, 2026. Applicant’s election without traverse of Invention I (Claims 1-10) in the reply filed on August 7th, 2026 is acknowledged. Claim Objections Claim6 is objected to because of the following informalities: Claim 6 recites “wherein a central axis of the surface coil intersects with a pulp of the finger” in lines 2-3, but should read “wherein a central axis of the surface coil is configured to intersect with a pulp of the finger” Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-10 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. The term “approximately” in claim 1 is a relative term which renders the claim indefinite. The term “approximately” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. Claim 1 recites “wherein the sequence of gradient pulses is configured to select a target region of the finger” in lines 10-11. It is unclear as to how a “sequence of gradient pulses” can be “configured to select a target region of the finger”. Clarification is requested. Claim 1 recites “a receive signal” in line 12. It is unclear as to whether this limitation should have recited “a received signal” instead, or if the limitation was written as “a receive signal” intentionally. The term “approximately” in claim 7 is a relative term which renders the claim indefinite. The term “approximately” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Gomes (U.S. Publication No. 2022/0155390) teaches a method for performing magnetic resonance imaging is provided (Abstract), comprising a single-sided gradient coil set configured to deliver a plurality of gradient pulses orthogonal to the inhomogeneous permanent gradient field ([0185]) and the use of an adiabatic pulse, which is used to compensate for a permanent gradient is multi-scan extension of cross-term spatiotemporal encoding (xSPEN), a pulse sequence using a type of adiabatic pulse referred to as a chirp pulse. The chirp pulse is one where different wavelengths or colors are not distributed uniformly over the temporal envelope of the pulse. As a result, this pulse affects different parts of space at different times, creating signals that refocus at different points along the acquisition. Exploiting these characteristics of a chirp pulse can allow for the encoding of spatial information using the permanent gradient and a pulsed gradient ([0169]). Iannello (U.S. Publication No. 2016/0011290; cited by Applicant) teaches a non-invasive, in-vivo measurement of blood constituents using a portable nuclear magnetic resonance device (Abstract), including measuring glucose levels in blood using NMR spectroscopy. The 1H spectrum of blood is shown in FIG. 1. Resonances due to chemical shifts of water (e.g., 4.79 ppm), glucose (e.g., 5.25 ppm), and lactate (e.g., 1.34 ppm) are clearly visible. To determine blood glucose levels, a device that provides a configuration of permanent magnets can be used to create the steady Bo field with only a very small amount of magnetic field leaking outside of the device. After a finger is inserted into the device, and an NMR spectrum can be obtained. The glucose level in the blood then can be determined by calculating the area under the glucose peak relative to the area under the water peak. This ratio then can be compared against a standard to obtain the actual glucose level. Yet certain exemplary embodiments can require a high level of uniformity of the magnetic field (less than 0.2 ppm) to resolve the chemical shifts with a reasonable degree of accuracy ([0033]). Further, Iannello teaches a series of pulses known as a Carr-Purcell-Meiboom-Gill (“CPMG”) pulse sequence, which is shown in FIG. 3, can be applied. To generate what is known as a spin-echo train, a 90-degree pulse first can be applied, followed by 180-degree pulse applied with a delay time τ. After this 180-degree pulse, additional 180-degree pulses are applied with an interval 2τ, also known as the echo time Te. After each 180-degree pulse is applied, the direction of precession of the hydrogen nuclei is reversed such that the phase spread of the nuclei begins to reverse, reaching coherence (focus) at a time τ after the pulse. At this time of coherence, data can be acquired. Extending this concept, 180-degree pulses can be applied at times τ, 3τ, 5τ, etc., and data can be acquired at times 2τ, 4τ, 6τ, etc. The refocusing that occurs at these times can cause what is referred to as an “echo”. By acquiring the echo signals, the effect of inhomogeneity of the Bo field can be minimized. As a result, the magnetic moments in the transverse plane attenuate with a time constant T2 instead of the much smaller T2*. The value of T2 then can be determined based on the decay observed with each subsequent acquisition. Kabasawa (U.S. Publication No. 2005/0134266) teaches a magnetic resonance imaging apparatus and magnetic resonance imaging method (Abstract), wherein the magnet system 21 comprises a static magnetic field magnet section 212, a gradient coil section 213, and an RF coil section 214 ([0038]) and wherein the gradient coil section 213 generates gradient magnetic fields for giving gradients to the intensity of the static magnetic field generated by the static magnetic field magnet section 212 for incorporating three-dimensional positional information into magnetic resonance signals received by the RF coil section 214. The gradient magnetic fields generated by the gradient coil section 213 include three types of magnetic fields: a slice selective gradient magnetic field, a readout gradient magnetic field, and a phase encoding gradient magnetic field. To generate these gradient magnetic fields, the gradient coil section 213 comprises three gradient coils corresponding to the gradient magnetic fields ([0041]). Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHANEL J YOON whose telephone number is (571) 272-2695. The examiner can normally be reached on Monday-Friday 9:00AM-5:00PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Alexander Valvis can be reached on 571-272-4233. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see https://ppair-my.uspto.gov/pair/PrivatePair. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CHANEL J YOON/Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Aug 08, 2024
Application Filed
Oct 20, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12648765
ENDOSCOPE PUNCTURE NEEDLE
4y 6m to grant Granted Jun 09, 2026
Patent 12582321
CARDIAC DIASTOLIC FUNCTION ASSESSMENT METHOD, DEVICE, AND SYSTEM
4y 4m to grant Granted Mar 24, 2026
Patent 12533069
Systems and Methods of Electrode Switching for Neurophysiological Sensing and Stimulation
6y 2m to grant Granted Jan 27, 2026
Patent 12521037
APPARATUS, SYSTEM, AND METHOD FOR DETECTING PHYSIOLOGICAL MOVEMENT FROM AUDIO AND MULTIMODAL SIGNALS
3y 5m to grant Granted Jan 13, 2026
Patent 12502112
SYSTEMS AND METHODS FOR EVALUATING ORAL FUNCTION
5y 11m to grant Granted Dec 23, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
56%
Grant Probability
94%
With Interview (+38.6%)
Low
PTA Risk
Based on 221 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month